Company Overview

NeuroMetrix is a commercial stage, neurostimulation and digital medicine company driving innovation to address chronic health conditions including chronic pain and diabetes.

NeuroMetrix

Founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and Technology, NeuroMetrix is a commercial stage, bioelectrical and digital medicine company driving innovation to address chronic health conditions including chronic pain and diabetes. Building on its roots in diagnostics technology, NeuroMetrix applied the same science to develop its lead product, Quell®, an over-the-counter wearable therapeutic device for chronic pain. Quell is integrated into a digital health platform that helps patients optimize their therapy and decrease the impact of chronic pain on their quality of life. The company also markets DPNCheck®, a rapid point-of-care test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. Based in Waltham, Mass., NeuroMetrix maintains an active research effort and has several pipeline programs.

Chronic health conditions affecting over 1.5 billion people worldwide

NeuroMetrix Focus

  • $600 Billion Annual Cost in US alone

    $600 Billion Annual Cost in US alone

  • 100M+ or 1 in 3 persons in the US

    100M+ or 1 in 3 persons in the US

  • Devastating effect on quality of life

    Devastating effect on quality of life

  • Inactivity, anxiety, depression, sleep, and risk of addiction with prescription opiates

    Inactivity, anxiety, depression, sleep, and risk of addiction with prescription opiates

  • Affects 30 million Americans

    Affects 30 million Americans

  • 50% of adults with diabetes have neuropathy

    50% of adults with diabetes have neuropathy

  • 350m worldwide

    350m worldwide

  • Neuropathy is one of the most costly complications of diabetes

    Neuropathy is one of the most costly complications of diabetes

  • People with chronic pain are almost 4X more likely to have a sleep disorder

    People with chronic pain are almost 4X more likely to have a sleep disorder

  • Conditions like Restless Leg Syndrome are under served

    Conditions like Restless Leg Syndrome are under served

  • 50% of those with chronic pain say sleep difficulties interfere with work

    50% of those with chronic pain say sleep difficulties interfere with work

  • Strong linkage with chronic pain

    Strong linkage with chronic pain

Proven Business Model

NeuroMetrix is driven to solve unmet healthcare needs in large market segments. The company’s expertise in neuro technology and digital health is applied to create meaningful innovation. In a recent clinical study of Quell users, 81% of participants reported an improvement in their chronic pain, and 67% reported a reduction in use of pain medications. NeuroMetrix’s highly effective “Razor / Razor Blade” approach maximizes customer lifetime value and by leveraging consumer and patient data to engage end users over time. The transition to consumer health, and expansion into major US retailers, has resulted in 7 quarters of sequential growth.

  • Best Buy
  • Bed Bath
  • CVS Pharmacy
  • Target
  • Walgreens